Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Blueprint Medicines Corporation
Scientific Title
An International, Multicenter, Open-label, Randomized, Phase 3 Study of BLU-285 vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic Gastrointestinal Stromal Tumor (GIST)